These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30207419)

  • 21. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors.
    Reid S; Cragun D; Tezak A; Weidner A; Moore J; Mayer IA; Shu XO; Ye F; Fan R; Vadaparampil S; Pal T
    Genet Med; 2020 Jun; 22(6):1088-1093. PubMed ID: 32066870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer.
    Halbert Ch; Kessler L; Collier A; Paul Wileyto E; Brewster K; Weathers B
    Clin Genet; 2005 Sep; 68(3):222-7. PubMed ID: 16098010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.
    Thompson HS; Sussner K; Schwartz MD; Edwards T; Forman A; Jandorf L; Brown K; Bovbjerg DH; Valdimarsdottir HB
    Genet Test Mol Biomarkers; 2012 Nov; 16(11):1257-62. PubMed ID: 23057569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors.
    Rajpal N; Muñoz J; Peshkin BN; Graves KD
    J Genet Couns; 2017 Dec; 26(6):1221-1237. PubMed ID: 28374142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors.
    Pinheiro LC; Samuel CA; Reeder-Hayes KE; Wheeler SB; Olshan AF; Reeve BB
    Breast Cancer Res Treat; 2016 Oct; 159(3):535-43. PubMed ID: 27585477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.
    Pal T; Vadaparampil S; Betts J; Miree C; Li S; Narod SA
    Genet Test; 2008 Sep; 12(3):401-7. PubMed ID: 18752448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the efficacy of a paraprofessional delivered telephonic psychoeducational intervention on emotional well-being in African American breast cancer survivors.
    Ashing KT; George M
    Support Care Cancer; 2020 Mar; 28(3):1163-1171. PubMed ID: 31203512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.
    Conley CC; Ketcher D; Reblin M; Kasting ML; Cragun D; Kim J; Ashing KT; Knott CL; Hughes-Halbert C; Pal T; Vadaparampil ST
    J Genet Couns; 2020 Jun; 29(3):410-422. PubMed ID: 31912597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
    McCarthy AM; Bristol M; Domchek SM; Groeneveld PW; Kim Y; Motanya UN; Shea JA; Armstrong K
    J Clin Oncol; 2016 Aug; 34(22):2610-8. PubMed ID: 27161971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.
    Kessler L; Domchek S; Stopfer J; Halbert CH
    Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral beliefs about genetic counseling among high-risk Latina breast cancer survivors in Florida and Puerto Rico.
    Rivera Rivera JN; Conley CC; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Ricker C; Quinn GP; Soliman H; Vadaparampil ST
    Cancer Med; 2023 Feb; 12(4):4701-4706. PubMed ID: 35941731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning.
    Metcalfe KA; Eisen A; Wright F; Poll A; Candib A; McCready D; Cil T; Armel S; Silberman Y; Brennenstuhl S; Narod SA
    Breast Cancer Res Treat; 2022 Feb; 191(3):631-641. PubMed ID: 34846626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A qualitative exploration of race-based differences in social support needs of diverse women with breast cancer on adjuvant therapy.
    Paladino AJ; Anderson JN; Graff JC; Krukowski RA; Blue R; Jones TN; Buzaglo J; Kocak M; Vidal GA; Graetz I
    Psychooncology; 2019 Mar; 28(3):570-576. PubMed ID: 30636189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
    Pal T; Bonner D; Kim J; Monteiro AN; Kessler L; Royer R; Narod SA; Vadaparampil ST
    Breast J; 2013; 19(2):189-92. PubMed ID: 23320992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
    Lerman C; Hughes C; Benkendorf JL; Biesecker B; Kerner J; Willison J; Eads N; Hadley D; Lynch J
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):361-7. PubMed ID: 10207641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.